When was NIMBLE Diagnostics founded?

NIMBLE Diagnostics was founded in 2022 and raised its 1st funding round within a year of its incorporation.

Where is NIMBLE Diagnostics located?

NIMBLE Diagnostics is headquartered in Badalona, Spain.

How many employees does NIMBLE Diagnostics have?

As of Sep 30, 2026, the latest employee count at NIMBLE Diagnostics is 18.

Is NIMBLE Diagnostics a funded company?

NIMBLE Diagnostics is a funded company, having raised a total of $1.08M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 19, 2022.

When was the latest funding round of NIMBLE Diagnostics?

NIMBLE Diagnostics' latest funding was a $***** Grant (prize money) round on Oct 31, 2023, with participation from 1 investor.

Where does NIMBLE Diagnostics rank among its competitors?

NIMBLE Diagnostics ranks 10th amongst 114 active competitors, of which 23 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Imperative Care, which secured $100M in Mar, 2026.

Who are the top competitors of NIMBLE Diagnostics?

NIMBLE Diagnostics' top competitors include Eko Health, Imperative Care and LUMA Vision. Among them, Imperative Care secured the most recent funding round in March, 2026.

NIMBLE Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of diagnostic device for the detection of cardiovascular conditions. The company offers a non-invasive device called the Nimble System that measures and quantifies stent malfunction, allowing patients to be monitored over time independently of the stent’s location.

Website: dxnimble.com
Social
Email ID: *****@dxnimble.com

Key Metrics

Founded Year

2022

Location

Badalona, Spain

Stage

Seed

Total Funding

$1.08M in 4 rounds

Latest Funding Round

Grant (prize money), Oct 31, 2023, $*****

Investors

Ship2B & 5 more

Ranked

10^th among 114 active competitors

Employee Count

18 as on Sep 30, 2026

Similar Companies

Eko Health & 87 more

View NIMBLE Diagnostics' full profile

NIMBLE Diagnostics has raised a total funding of $1.08M over 4 rounds. Its first funding round was on Apr 19, 2022. Its latest funding round was a Grant (prize money) round on Oct 31, 2023 for $*****. 1 investor participated in its latest round. NIMBLE Diagnostics has 6 institutional investors.

Here is the list of recent funding rounds of NIMBLE Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 31, 2023	1392057	Grant (prize money)	9306267	8832526	4571301	9187436
Jun 01, 2023	2633259	Grant (prize money)	2972055	9562731	1109765	Europa
Jan 15, 2023	2233264	Seed	2073475	2930689	Grow Venture Partners	Inveniam Group & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of NIMBLE Diagnostics's funding rounds and investors

The founders of NIMBLE Diagnostics are Carolina Gálvez-Montón, Oriol Rodriguez Leor and O'Callaghan JM Spanish.

Here are the details of NIMBLE Diagnostics' key team members:

Carolina Gálvez-Montón: Co-founder and CSO of NIMBLE Diagnostics.
Oriol Rodriguez Leor: Co-Founder of NIMBLE Diagnostics.
O'Callaghan JM Spanish: Co-Founder of NIMBLE Diagnostics.

View details of NIMBLE Diagnostics's Founder profiles and Board Members

NIMBLE Diagnostics' employee count trend

NIMBLE Diagnostics has 18 employees as of Sep 26. Here is NIMBLE Diagnostics's employee count trend over the years:

Employee count trend for NIMBLE Diagnostics

Uncover NIMBLE Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NIMBLE Diagnostics include Eko Health, Imperative Care and LUMA Vision. Here is the list of Top 10 competitors of NIMBLE Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Eko Health 2013, Emeryville (United States), Series D	Manufacturer of digital stethoscopes and software for heart disease detection	$195M	Artis Ventures, EDBI & 35 others	73/100
2nd	Imperative Care 2015, Campbell (United States), Series E	Provider of access catheters for cardiovascular diagnosis and treatment	$596M	Ally Bridge Group, Perceptive Advisors & 21 others	66/100
3rd	LUMA Vision 2017, Dublin (Ireland), Series A	Developer of interventional cardiac imaging devices	$42.3M	Life Sciences Partners, imec.xpand & 11 others	62/100
4th	Insight Lifetech 2015, Shenzhen (China), Public	Developer of ultrathin pressure microcatheter for coronary stenosis.	$42.7M	Sequoia Capital China, Qiming Venture Partners ... & 9 others	59/100
5th	Laza Medical 2022, Los Gatos (United States), Series A	AI-powered robotically-assisted imaging solutions for cardiovascular interventions	$36M	The Capital Partnership, Shifamed & 5 others	57/100
6th	Spectrum Dynamics 2000, Morges (Switzerland), Acquired	Manufacturer of cardiac imaging systems	$29M	Gandir Group, Hobart Group	57/100
7th	VerAvanti 2012, Redmond (United States), Series B	Innovating intravascular imaging with advanced single-use endoscopes for enhanced patient care	$38.9M	HHS	45/100
8th	Orphalan 2011, Paris (France), Funding Raised	Developer and provider of access to innovative treatments to patients with rare diseases	-	Advent Life Sciences, Kreos Capital & 1 others	41/100
9th	HD Medical Group 2005, Melbourne (Australia), Series A	Developer of stethoscopes with integrated phonocardiogram visual display	$5.18M	Maxim Integrated, Nexxus Ventures & 1 others	41/100
10th	NIMBLE Diagnostics 2022, Badalona (Spain), Seed	Developer of diagnostic device for the detection of cardiovascular conditions	$1.08M	EIC Fund, Namarel Ventures & 4 others	40/100